DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously
Bispecific antibodies can bind to two distinct targets though the fusion of two different Fv regions. In this study, the authors develop DutaFabs that present two separated and independent antigen binding sites within the same Fv region, giving rise to bispecific Fab fragments.
Guardado en:
Autores principales: | Roland Beckmann, Kristian Jensen, Sebastian Fenn, Janina Speck, Katrin Krause, Anastasia Meier, Melanie Röth, Sascha Fauser, Raymond Kimbung, Derek T. Logan, Martin Steegmaier, Hubert Kettenberger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/70c0f8f5eaae4c48be3ad457ee0a7a4b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect of DNA sequence of Fab fragment on yield characteristics and cell growth of E. coli
por: Antti Kulmala, et al.
Publicado: (2017) -
Trastuzumab- and Fab′ fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo
por: Duan D, et al.
Publicado: (2018) -
The Functional Assessment of Balance in Concussion (FAB-C) Battery
por: Thaer Manaseer, et al.
Publicado: (2021) -
Cranial morphology of Deudorix isocrates (Fab.) (Lepidoptera: Lycaenidae) larvae
por: Ravindrakumar D. Patil, et al.
Publicado: (2021) -
Production of antibody fragment (Fab) throughout Escherichia coli fed-batch fermentation process: Changes in titre, location and form of product
por: Jalalirad,Reza
Publicado: (2013)